| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
-9-Tetrahydrocannabinol Enhances Breast Cancer Growth and Metastasis by Suppression of the Antitumor Immune Response1
Departments of
*
Microbiology and Immunology, and
Pharmacology and Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA 23298
In the current study, we tested the central hypothesis that exposure to 
-9-tetrahydrocannabinol (9-THC), the major psychoactive component in marijuana, can lead to enhanced growth of tumors that express low to undetectable levels of cannabinoid receptors by specifically suppressing the antitumor immune response. We demonstrated that the human breast cancer cell lines MCF-7 and MDA-MB-231 and the mouse mammary carcinoma 4T1 express low to undetectable levels of cannabinoid receptors, CB1 and CB2, and that these cells are resistant to 9-THC-induced cytotoxicity. Furthermore, exposure of mice to 9-THC led to significantly elevated 4T1 tumor growth and metastasis due to inhibition of the specific antitumor immune response in vivo. The suppression of the antitumor immune response was mediated primarily through CB2 as opposed to CB1. Furthermore, exposure to 9-THC led to increased production of IL-4 and IL-10, suggesting that 9-THC exposure may specifically suppress the cell-mediated Th1 response by enhancing Th2-associated cytokines. This possibility was further supported by microarray data demonstrating the up-regulation of a number of Th2-related genes and the down-regulation of a number of Th1-related genes following exposure to 9-THC. Finally, injection of anti-IL-4 and anti-IL-10 mAbs led to a partial reversal of the 9-THC-induced suppression of the immune response to 4T1. Such findings suggest that marijuana exposure either recreationally or medicinally may increase the susceptibility to and/or incidence of breast cancer as well as other cancers that do not express cannabinoid receptors and are resistant to 9-THC-induced apoptosis.
This article has been cited by other articles:
|
|
 |
|
  Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer Mol. Cancer Ther., November 1, 2009; 8(11): 3117 - 3129.
|
|
|
|
 |
|
 V. L. Hegde, S. Hegde, B. F. Cravatt, L. J. Hofseth, M. Nagarkatti, and P. S. Nagarkatti Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids: Involvement of Regulatory T Cells Mol. Pharmacol., July 1, 2008; 74(1): 20 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bifulco, A. M. Malfitano, S. Pisanti, and C. Laezza Endocannabinoids in endocrine and related tumours Endocr. Relat. Cancer, June 1, 2008; 15(2): 391 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Gillison, G. D'Souza, W. Westra, E. Sugar, W. Xiao, S. Begum, and R. Viscidi Distinct Risk Factor Profiles for Human Papillomavirus Type 16-Positive and Human Papillomavirus Type 16-Negative Head and Neck Cancers J Natl Cancer Inst, March 19, 2008; 100(6): 407 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sarfaraz, V. M. Adhami, D. N. Syed, F. Afaq, and H. Mukhtar Cannabinoids for Cancer Treatment: Progress and Promise Cancer Res., January 15, 2008; 68(2): 339 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhang, J. F. Wang, G. Kunos, and J. E. Groopman Cannabinoid Modulation of Kaposi's Sarcoma Associated Herpesvirus Infection and Transformation Cancer Res., August 1, 2007; 67(15): 7230 - 7237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pacher, S. Batkai, and G. Kunos The Endocannabinoid System as an Emerging Target of Pharmacotherapy Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ligresti, A. S. Moriello, K. Starowicz, I. Matias, S. Pisanti, L. De Petrocellis, C. Laezza, G. Portella, M. Bifulco, and V. Di Marzo Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1375 - 1387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Caffarel, D. Sarrio, J. Palacios, M. Guzman, and C. Sanchez {Delta}9-Tetrahydrocannabinol Inhibits Cell Cycle Progression in Human Breast Cancer Cells through Cdc2 Regulation. Cancer Res., July 1, 2006; 66(13): 6615 - 6621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Sarafian, N. Habib, M. Oldham, N. Seeram, R.-P. Lee, L. Lin, D. P. Tashkin, and M. D. Roth Inhaled marijuana smoke disrupts mitochondrial energetics in pulmonary epithelial cells in vivo Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1202 - L1209. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
